Search Results - "Garrido, Federico"

Refine Results
  1. 1

    HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy by Anderson, Per, Aptsiauri, Natalia, Ruiz-Cabello, Francisco, Garrido, Federico

    Published in Cellular & molecular immunology (01-03-2021)
    “…T cell-mediated immune therapies have emerged as a promising treatment modality in different malignancies including colorectal cancer (CRC). However, only a…”
    Get full text
    Journal Article
  2. 2

    The urgent need to recover MHC class I in cancers for effective immunotherapy by Garrido, Federico, Aptsiauri, Natalia, Doorduijn, Elien M, Garcia Lora, Angel M, van Hall, Thorbald

    Published in Current opinion in immunology (01-04-2016)
    “…Highlights • Tumor immune escape compromises the efficacy of cancer immunotherapy. • Loss of MHC class I expression is a frequent event in cancer cells. •…”
    Get full text
    Journal Article
  3. 3

    “Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy by Garrido, Federico, Cabrera, Teresa, Aptsiauri, Natalia

    Published in International journal of cancer (15-07-2010)
    “…The ability of cancer cells to escape from the natural or immunotherapy‐induced antitumor immune response is often associated with alterations in the tumor…”
    Get full text
    Journal Article
  4. 4

    MHC heterogeneity and response of metastases to immunotherapy by Algarra, Ignacio, Garrido, Federico, Garcia-Lora, Angel M.

    Published in Cancer and metastasis reviews (01-06-2021)
    “…In recent years, immunotherapy has proven to be an effective treatment against cancer. Cytotoxic T lymphocytes perform an important role in this anti-tumor…”
    Get full text
    Journal Article
  5. 5

    Metastases in immune-mediated dormancy: a new opportunity for targeting cancer by Romero, Irene, Garrido, Federico, Garcia-Lora, Angel M

    Published in Cancer research (Chicago, Ill.) (01-12-2014)
    “…The aim of any anticancer treatment is to avoid, control, or eliminate disseminated tumor cells. Clinical and experimental evidence has revealed that…”
    Get full text
    Journal Article
  6. 6

    Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes by Bernal, Monica, Ruiz-Cabello, Francisco, Concha, Angel, Paschen, Annette, Garrido, Federico

    Published in Cancer Immunology, Immunotherapy (01-09-2012)
    “…Classical MHC molecules present processed peptides from endogenous protein antigens on the cell surface, which allows CD8 + cytotoxic T lymphocytes (CTLs) to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Scientific production in biodiversity: the gender gap continues in Brazilian universities by León, Federico Garrido-DE, Romero, Jair H Castro, Garey, Michel V, Eleuterio, Ana Alice

    Published in Anais da Academia Brasileira de Ciências (01-01-2023)
    “…Scientometrics enables us to comprehend the interests and trends in scientific knowledge production and dissemination. In this study, we evaluate the effects…”
    Get full text
    Journal Article
  9. 9
  10. 10

    ‘No State, No Masters’: Café Lavandería in Tokyo, Music, and Anticapitalism in a Cultural Environment by González Dávila, María José, Pérez Garrido, Federico Fco

    Published in Arts (Basel) (01-08-2024)
    “…This paper is part of a series of research that these authors are conducting to study the linguistic landscape of the Tokyo megacity. In this instance, our…”
    Get full text
    Journal Article
  11. 11
  12. 12

    MHC class I antigens, immune surveillance, and tumor immune escape by Garcia-Lora, Angel, Algarra, Ignacio, Garrido, Federico

    Published in Journal of cellular physiology (01-06-2003)
    “…Oncogenic transformation in human and experimental animals is not necessarily followed by the appearance of a tumor mass. The immune system of the host can…”
    Get full text
    Journal Article
  13. 13

    Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach by Blanco-Calvo, Moisés, Concha, Ángel, Figueroa, Angélica, Garrido, Federico, Valladares-Ayerbes, Manuel

    “…Colorectal cancer is a heterogeneous disease that manifests through diverse clinical scenarios. During many years, our knowledge about the variability of…”
    Get full text
    Journal Article Book Review
  14. 14
  15. 15

    The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture by Garrido, Federico, Perea, Francisco, Bernal, Mónica, Sánchez-Palencia, Abel, Aptsiauri, Natalia, Ruiz-Cabello, Francisco

    Published in Vaccines (Basel) (27-02-2017)
    “…Tumor immune escape is associated with the loss of tumor HLA class I (HLA-I) expression commonly found in malignant cells. Accumulating evidence suggests that…”
    Get full text
    Journal Article
  16. 16

    MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy by Romero, Irene, Garrido, Cristina, Algarra, Ignacio, Chamorro, Virginia, Collado, Antonia, Garrido, Federico, Garcia-Lora, Angel M

    Published in Frontiers in immunology (29-01-2018)
    “…An individual tumor can present intratumoral phenotypic heterogeneity, containing tumor cells with different phenotypes that do not present irreversible…”
    Get full text
    Journal Article
  17. 17

    Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients by Montes, Paola, Kerick, Martin, Bernal, Mónica, Hernández, Francisca, Jiménez, Pilar, Garrido, Pilar, Márquez, Ana, Jurado, Manuel, Martin, Javier, Garrido, Federico, Ruiz-Cabello, Francisco

    Published in Oncotarget (11-12-2018)
    “…The Revised International Prognostic Score and some somatic mutations in myelodysplastic syndrome (MDS) are independently associated with transformation to…”
    Get full text
    Journal Article
  18. 18

    Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab by Garrido, Greta, Rabasa, Ailem, Garrido, Cristina, Chao, Lisset, Garrido, Federico, García-Lora, Ángel M, Sánchez-Ramírez, Belinda

    Published in Frontiers in pharmacology (06-10-2017)
    “…Defining how epidermal growth factor receptor (EGFR)-targeting therapies influence the immune response is essential to increase their clinical efficacy. A…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A new extract of the plant Calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation by Jiménez-Medina, Eva, Garcia-Lora, Angel, Paco, Laura, Algarra, Ignacio, Collado, Antonia, Garrido, Federico

    Published in BMC cancer (05-05-2006)
    “…Phytopharmacological studies of different Calendula extracts have shown anti-inflammatory, anti-viral and anti-genotoxic properties of therapeutic interest. In…”
    Get full text
    Journal Article